Related Experiment Videos
[Genetic risk factors for myocardial infarct]
1Abteilung Kardiologie, Johann-Wolfgang-Goethe-Universität Frankfurt/Main. D.Walter@em.uni-frankfurt.de
Insights
Genetic factors significantly influence coronary artery disease (CAD) and myocardial infarction risk, especially in younger individuals. Understanding these genetic polymorphisms is key for personalized prevention strategies.
Area of Science:
- Cardiovascular Genetics
- Molecular Medicine
- Disease Pathogenesis
Context:
- Coronary artery disease (CAD) and myocardial infarction (MI) result from complex interactions between genetic and environmental factors.
- In early-onset MI, genetic predisposition may be the primary driver of disease development.
- Numerous candidate genes are implicated in CAD and MI pathogenesis, highlighting the role of genetic variations.
Purpose:
- To explore the role of genetic polymorphisms in the development of coronary artery disease and myocardial infarction.
- To understand how gene variations influence key biological pathways relevant to cardiovascular health.
- To assess the clinical significance of genetic polymorphisms in risk stratification and drug response.
Summary:
- Gene polymorphisms affect blood pressure regulation, lipid metabolism, endothelial function, coagulation, thrombosis, and restenosis after interventions.
- These genetic variations can amplify individual risk and influence the efficacy and safety of cardiovascular medications.
- Identifying and understanding genetic risk factors is crucial for early detection and targeted treatment of high-risk individuals.
Impact:
- Integrating genetic risk profiles into clinical practice can enhance primary and secondary prevention of CAD.
- Personalized risk assessment based on genetic data may optimize treatment strategies for myocardial infarction.
- Advances in understanding genetic contributions will refine the classical risk factor theory for cardiovascular disease.
Abstract:
Interactions of genetic and environmental risk factors influence the susceptibility to coronary artery disease (CAD) and myocardial infarction. In myocardial infarction occurring at young age, genetics of this multifactorial disease may be the leading factor. A number of candidate genes have been implicated in the pathogenesis of CAD and myocardial infarction. Mutations in the DNA sequence (gene polymorphisms) have been identified that appear to play a crucial role in blood pressure regulation, lipid metabolism, endothelial function, in the pathophysiology of coagulation or thrombosis, or in interventional cardiology by interfering with restenosis development. Genetic polymorphisms seem to be clinically important because they not only potentiate the individual risk under certain circumstances, but they also determine safety and effectiveness of commonly prescribed drugs. Understanding the complexity and functional relevance of genetic risk factors will be useful in early detection and treatment of individuals that are exposed to higher risk for myocardial infarction. Thus it is important to include genetic risk factors in the concept of the classical risk factor theory. Potentially in future a genetic risk profile including relevant polymorphisms may be an essential part of the clinicians' knowledge in primary and secondary prevention of coronary artery disease.